| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | GW-405833 | CTRPv2 | pan-cancer | AAC | -0.061 | 0.07 |
| mRNA | BRD-K13999467 | CTRPv2 | pan-cancer | AAC | -0.064 | 0.07 |
| mRNA | TL-2-105 | GDSC1000 | pan-cancer | AAC | -0.057 | 0.07 |
| mRNA | Erlotinib | UHNBreast | pan-cancer | AAC | 0.49 | 0.07 |
| mRNA | PX-12 | CTRPv2 | pan-cancer | AAC | -0.05 | 0.07 |
| mRNA | RO-3306 | GDSC1000 | pan-cancer | AAC | 0.061 | 0.08 |
| mRNA | tigecycline | CTRPv2 | pan-cancer | AAC | -0.084 | 0.08 |
| mRNA | MS-275 | FIMM | pan-cancer | AAC | 0.23 | 0.08 |
| mRNA | I-BET-762 | GDSC1000 | pan-cancer | AAC | -0.048 | 0.08 |
| mRNA | AR-42 | GDSC1000 | pan-cancer | AAC | -0.053 | 0.08 |